-
REVISITING THE CASE FOR REFORM: THE IMPACT ASSESSMENT BEHIND THE EU HTA REGULATION
Aug 11, 2026, 17:16 PM -
GIVING A VOICE TO PATIENTS IN DRUG REIMBURSEMENT: A CROSS-COUNTRY COMPARATIVE ANALYSIS
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS IN HR+/HER2- BREAST CANCER: EVIDENCE FROM MEXICO
Aug 11, 2026, 17:16 PM -
BEYOND CLAIMS DATA: A LEGALLY GOVERNED INTEGRATED EHR-CLAIMS DATABASE FOR REAL-WORLD EVIDENCE GENERATION IN JAPAN
Aug 11, 2026, 17:16 PM -
DEVELOPMENT AND CONTENT VALIDATION OF A WELL-BEING INSTRUMENT FOR YOUNGER POPULATIONS IN ECONOMIC EVALUATIONS: THE WELL-BEING OF YOUTH INSTRUMENT (WELL-Y)
Aug 11, 2026, 17:16 PM -
REAL-WORLD EVIDENCE STUDY OF TREATMENT PATTERNS IN PEDIATRIC AND ADULT PATIENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN ALBERTA
Aug 11, 2026, 17:16 PM -
UNIVERSAL NIRSEVIMAB VERSUS MATERNAL RESPIRATORY SYNCYTIAL VIRUS (RSV) IMMUNIZATION: A COST-EFFECTIVENESS ANALYSIS IN BRAZIL
Aug 11, 2026, 17:16 PM -
DECISION-CONTEXT METADATA IMPROVES AI-GUIDED ECONOMIC MODEL-STRUCTURE TRIAGE: A 15-CASE NON-ONCOLOGY HTA VALIDATION
Aug 11, 2026, 17:16 PM -
CHASING ASYMMETRIES: MAPPING THE AGE-RELATED TOLL OF PNEUMONIA
Aug 11, 2026, 17:16 PM -
EXPERIMENTED LONG-ACTING INJECTABLE ANTIRETROVIRAL THERAPY AND LINK WITH AMBULATORY MEDICINE AMONG ADULT PEOPLE LIVING WITH HIV: THE REAL-LIFE PANTER STUDY
Aug 11, 2026, 17:16 PM -
COSTS AND COST DRIVERS OF INFLAMMATORY BOWEL DISEASE IN THE UNITED KINGDOM: EVIDENCE FROM A LARGE PATIENT SURVEY USING TWEEDIE REGRESSION
Aug 11, 2026, 17:16 PM -
CURRENT TREATMENT PATTERNS AND SAFETY OUTCOMES IN RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) WITH AN NPM1 MUTATION: A SYSTEMATIC LITERATURE REVIEW (SLR)
Aug 11, 2026, 17:16 PM -
PROJECTING THE FUTURE BURDEN OF NON-MUSCLE INVASIVE BLADDER CANCER IN EUROPE: AN EPIDEMIOLOGICAL MODEL FRAMEWORK BASED ON REAL-WORLD DATA
Aug 11, 2026, 17:16 PM -
ASSESSING THE REAL-WORLD EFFECTIVENESS OF SPESOLIMAB IN GENERALIZED PUSTULAR PSORIASIS: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
ASSESSING HEALTH-RELATED QUALITY OF LIFE AMONG CHILDREN AND ADOLESCENTS WITH VISION IMPAIRMENT USING THE EQ-5D-Y-3L INSTRUMENT IN BRAZIL
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF ETRANACOGENE DEZAPARVOVEC VERSUS FACTOR IX PROPHYLAXIS FOR SEVERE OR MODERATELY SEVERE HAEMOPHILIA B IN THE UNITED KINGDOM
Aug 11, 2026, 17:16 PM -
BENCHMARKING DAY SURGERY POTENTIAL IN HUNGARY USING THE BEDS METHODOLOGY: THEORETICAL RESERVES IN CASE VOLUMES AND HOSPITALIZATION DAYS, 2015-2025
Aug 11, 2026, 17:16 PM -
IDENTIFICATION OF TREATMENT EFFECT MODIFIERS (TEMS) AND PROGNOSTIC FACTORS (PFS) IN MATCHING-ADJUSTED INDIRECT COMPARISONS (MAICS)- A SYSTEMATIC LITERATURE REVIEW (SLR)
Aug 11, 2026, 17:16 PM -
INDIRECT COMPARISONS FOR HEALTH TECHNOLOGY ASSESSMENT: A PRACTICAL METHODOLOGICAL GUIDE AND TIPS WITH INSIGHTS FROM THE FRENCH TRANSPARENCY COMMISSION
Aug 11, 2026, 17:16 PM -
EXPLORING THE IMPACT OF EVOLVING TREATMENT PATHWAYS ON COMPARATOR RELEVANCE IN EUROPEAN ONCOLOGY HEALTH TECHNOLOGY ASSESSMENTS (HTAS)
Aug 11, 2026, 17:16 PM
